Nuveen International Eq Idx R6 TCIEX

Medalist Rating as of | See Nuveen Investment Hub
  • NAV / 1-Day Return 24.41  /  −0.61 %
  • Total Assets 26.6 Bil
  • Adj. Expense Ratio
    0.050%
  • Expense Ratio 0.050%
  • Distribution Fee Level Low
  • Share Class Type Retirement, Large
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 2.80%
  • Turnover 8%

USD | NAV as of Sep 25, 2024 | 1-Day Return as of Sep 25, 2024, 10:18 PM GMT+0

Morningstar’s Analysis TCIEX

Will TCIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin Nuveen International Eq Idx R6's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings TCIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 15.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

2.46 645.4 Mil
Healthcare

ASML Holding NV

2.11 555.4 Mil
Technology

Msci Eafe Sep24 Ifus 20240920

1.75 460.4 Mil

Nestle SA

1.54 403.8 Mil
Consumer Defensive

AstraZeneca PLC

1.40 367.6 Mil
Healthcare

Shell PLC

1.33 348.6 Mil
Energy

Roche Holding AG

1.29 339.5 Mil
Healthcare

SAP SE

1.25 329.5 Mil
Technology

Novartis AG Registered Shares

1.25 328.5 Mil
Healthcare

Toyota Motor Corp

1.16 304.0 Mil
Consumer Cyclical

Sponsor Center